Genotype Matters: Vagus Nerve Atrophy in GBA-Associated Parkinson’s Disease
Objective: The aim of this study is to compare the right and left vagus nerve (VN) cross-sectional area (CSA) and autonomic symptoms in patients with…The Shape Of Sequence Effect In Parkinson’s Disease
Objective: The aim of this study is to objectively characterize and compare the temporal patterns of finger-tapping amplitude decrement in patients with Parkinson’s disease (PD)…Preservation of Cognition Following Intravenous Mesenchymal Stem Cell Therapy in Parkinson’s Disease: Secondary Analysis of a Randomized Trial
Objective: To evaluate longitudinal changes in global cognition following intravenous allogeneic bone marrow–derived mesenchymal stem cell (allo-hBM-MSC) therapy in Parkinson’s disease (PD). Background: Cognitive impairment…The Diagnostic Value of Dopaminergic-Glucose United PET Imaging in Parkinson’s disease
Objective: This study aimed to evaluate the diagnostic efficacy of DAT-FDG united PET imaging in differentiating PD from other parkinsonian disorders in real-world clinical settings…Systemic Inflammation and Cerebral Small Vessel Disease in Progressive Supranuclear Palsy
Objective: To assess the cerebral small vessel disease (CSVD) burden in progressive supranuclear palsy (PSP) and examine the relationships among peripheral inflammatory markers, CSVD imaging…Sex differences for clinical impact of APOEe4 mediated by Alzheimer’s pathology in people with Lewy body pathology
Objective: Assess whether Alzheimer’s (AD) or Lewy body (LB) pathologies mediate the association between APOEe4 and clinical profile differently for females and males with LB…Wearable-Derived Gait Biomarkers Predict Disease Severity and Quality of Life in Parkinson’s Disease: A Machine Learning and Mediation Analysis
Objective: To investigate whether wearable-derived gait biomarkers predict disease severity and health-related quality of life in Parkinson’s disease (PD) and to examine the mediating role…Structural-Functional Decoupling and Imaging Transcriptomics in Cognitive Impairment of Parkinson’s Disease
Objective: To examine SDI across cognitive stages of Parkinson’s disease (PD) and its associations with cortical thickness (CTh), cognition, and cell-type transcriptomic signatures. Background: Cognitive…Impact of Foslevodopa/Foscarbidopa Continuous Subcutaneous Infusion on Neuropsychiatric Symptoms in Clinical Practice: A Multicenter Study
Objective: To determine the incidence and risk factors of neuropsychiatric adverse events (AEs) in patients with Parkinson’s disease (PD) treated with foslevodopa/foscarbidopa continuous subcutaneous infusion…A composite oculomotor biomarker for differentiating Parkinson’s disease from multiple system atrophy
Objective: To evaluate whether a composite oculomotor index integrating multiple eye movement domains improves discrimination between PD and MSA. Background: Differentiating Parkinson’s disease (PD) from…
- « Previous Page
- 1
- …
- 63
- 64
- 65
- 66
- 67
- …
- 1942
- Next Page »